From the publishers of JADPRO
CAR T-Cell Therapy
Resource Center
Menu
Resources
Videos
Videos
Fast Facts
Quizzes
News & Literature Highlights
Case Studies
Advertisement
Patient Perspectives on Health-Related Quality of Life in Diffuse Large B-Cell Lymphoma Treated With CAR T-Cell Therapy: A Qualitative Study
Last Updated: Friday, July 17, 2026
Oncol Ther
Advertisement
Case Studies
ICANS or TIAN? Neurologic Toxicity Following CAR T-Cell Therapy in a Patient With Primary Central Nervous System Lymphoma
Identifying CRS in Patients Who Underwent CAR T-Cell Infusion
Cytopenias After CAR T-cell Therapy: Varying Predictive Markers, Duration
Fast Facts
Fast Facts #12: BCMA Targets
Advertisement
Quizzes
Test your knowledge of neurologic toxicity following CAR T-cell therapy in patients with primary central nervous system lymphoma
Test your knowledge on neurologic toxicity post-CAR T-cell therapy and CRS
Test your knowledge on cytopenias after CAR T-cell therapy